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CASPERSSON and his associates advanced a hypothesis on the' role of nucleic
acids in the biological synthesis of proteins (Caspersson, 1947). Several other
results suggested the role of nucleotides in the metabolism of tumors as well,
as a result of which many structural analogues of pyrimidine and purine deriva-
tives were synthesized and tested for anti-cancer and growth-inhibiting activity
(Roblin, Lampen, English, Cole and Vaughan, 1945; Kidder and Dewey, 1949;
Kidder, Dewey, Parks and Woodside, 1949; Sugiura, Hitchings, Cavalieri and
Stock, 1950; Burchenal, Bendich, Brown, Clian, Hitchings, Rhoads and Stock,
1949; Skipper, Bennet, Edwards, Bryan, Hutchison, Chapman and Bell, 1950;
Law, 1950 ; Lewis andCrossley, 1950.) However, little is known about the effect
of the naturally occurring nucleotides on tumor growth.
Parsons, Gulland and Barker (1946, 1947) described that in C57 mice the
growth of homologous methylcholanthrene sarcoma grafts was inhibited by
(yeast) ad'enylic acid or guanylic acid; uridyhc acid showed a growth-promoting
effect, whereas cytidylic acid had no effect. The exceRent review ofDyer (1949)
covers the pubhcations of some earlier authors, investigating the effect of several
nucleotides on tumor growth.
METHODS.
Since it wasexpected that the nucleotidesmight causerelatively smallchanges
in the rate of tumor growth, sensitive methods were sought. Ehrlich ascites
tumor was used; reviews on this tumor were given by Lettre' (1941), and more
recently by Klein (1950), and Klein and Klein (1951). The tumor was carried
in the abdominal cavity of Strong A mice. Tumor cells are free in the ascitic
fluid, usuaR without forming solid tumors. Ascitic fluid was harvested by
abdominal puncture under aseptic conditions, and the number of cells present in
the ascitic fluid counted in a hemacytometer. The percentage of inflammatory
cells was establishedby a smear, stainedaccording to the method ofPapanicolaou
(Papanicolaou and Traut, 1943). From these data the number of tumor cells in
I c.mm. of ascitic fluid was calculated, and inoculations were made aseptically
with known numbers of cancer cells. Within any one seriesthe control as well as
the experimental groups were inoculated with cancer cells originating from the
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The method used in this study offers the foRowing advantages :' (a) cancer
cells of known number and equal virulence are inoculated into the control, as
well as the experimental animals ; (b) upon intraperitoneal inoculation similar
ascitic tumors areproduced, whilesubcutaneousinoculationresults inthedevelop-
ment of solid tumors; (c) in case of intraperitoneal inoculation the action. of
substances upon the cancer cefls themselves may be tested without involving
such factors as tumor vascularization, differences in distribution of the injected
substances, etc. The error in thi's method is that there is always some micro-
scopic infiltration of sohd tissues in the peritoneal cavity (Klein, 1950; Klein
and Klein 1951). These infiltratin' cells are, of course, not included in our
cell counts.
Swiss mice, bred in our colony, were used for these studies. These mice were
maintained o'n Rockland Complete Rat Diet and water, ad libitum, and kept in
air-conditioned quarte'rs at 2P C. They were weighed daily. These mice were
greatly susceptible to th'e cancer cells ori'gi'nating from Strong A mice in which
the stock tumor was carried. The strain aspecificity ofthis tumor was discussed
by Klein (1950) and Klein and Klein (1951). Subcutaneous inoculations were
made into the caudal third of the back. Twenty-one days after inoculation the
animals were sacrificed, and their tumors dissected and weighed. Groups
receiving intraperitoneal injections of cancer ceHs were observed for mortailty
rate. Animals dying were autopsied, their ascitic fluid harvested and measured,
and the number of cancer ceHs per cubic miHimetre estabhshed as previously
descr'lbed.
Nucleotides were administered by daily subcutaneous injection, alternating
between the right and left flank. Adenosine-3-phosphoric acid was injected in
solution in 3-2 per cent disodium phosphate, adenosine triphosphate and adeno-
sine-5-phosphoric acid in normal saline warmed to about 37' C. The control
group in.Series I and V received corresponding amounts of disodium phosphate,
while the control groups in Series II, III, IV and VI were injected with similar
volumes of normal saline.
RESULTS.
According to prehminarv experiments the maximal dose of the nucleotides
which could be administered by subcutaneous injection daily without evident
toxic effect to Swiss mice during a period of 6 weeks was as follows: adenosine
triphosphate, I00 mg./kg.; adenosine-5-phospho'ric acid, 500 mg./kg. ; and adeno-
sine-3-phosphoric acid, 500 mg./kg. These doses were, therefore, used in aH the
final experiments.
Subcutaneou8 inoculation8.
In the first three series 2,000,000 cancer cells were inoculated while the fourth
series received 200,000 cells. The mean tumor weights 3 weeks after inoculation
are shown in Table 1. Adenosine-3-phosphoric acid exhibits a definite tumor-
inhibiting effect. Adenosine-5-phosphoric acid seems rather to enhance tumor
growth ; this may be morereadily evidenced in the series using a smaHer number
of inoculated ceHs. Adenosine triphosphate has no effect.
Intraperitoneal inoculation8.
In Series V I:000,000 cancer cells were inoculated intraperitoneally into
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triphosphate as weR as adenosine-5-phosphoric acid increases the death rate
of animals with ascitic tumors. In Series VI 10,000,000 cancer cells were
inoculated into groups of 15 mice. The usual doses of nucleotides were u8ed,
and one additional group received 10 mg./kg. adenosine triphosphate. The
results are shown inFig. 2. All nucleotides increase death rate oftumor-bearing
animals.
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FIG. l.-Effect of nucleotides on the death rat. of nrice inoculated intraperitoneaRy with
1,000,000 Ehrlich carcinoma cefls (Series V). Treatments: Control ; adenosine
triphosphate 100 mg./kg........... adenosine-3-phosphoric acid 500 mg./kg.-
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FIG. 2.-Effect of nuclootides on the death rate 'of mice inoculated intraperitoneally with
10,000,000 Ehrlich'carcinoms cells (Series VI). Treatments: Control ; adenosine
triphosphate 10 mg./kg.
- ; adenosine triphosphate 100 mg./kg
......... ; adeno
-
sme-3-phosphoric acid 500 mg./kg
-
- - -; adenosine-5-phosphoric acid 500 mg./kg.
Micebearing subcutaneous tumors lostweightprogressively, but nosignificant
difference was evidenced in this respect between control and nucleotide-treated
animals. Nucleotide-treated non-tumor-bearing animals exhibited no weight
loss. The weight ofintraperitoneaRy'inoculated mice increased gradually with
the development of the ascites, This increase was somewhat more expressed in
the control than in the treated groups, the difference being, however, statistically
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TABLEL-GroUP8Treated with Different Nucleotide8. Mean Tumor Weight8
in Gram8.
Adenosine-3- Adenosine-5- Adenosine
phosphoric acid phosphoric acid triphosphate
Serim I (2,000,000 cells)
Control. 500 mg./kg. 500 mg./kg. I00 mg./kg.
meem 11-3 7-6 11.0
SE 1.0 0-895 1-193
N 15.0 15.0 15.0
Serim 11 (2,000,000 cells):
Mean 10-4 5-74 10-6
SE 1-56 1.05 0-94
N 10.0 10.0 9.0
Serim IH (2,000,000 cells)
Mean 9-82 11-7
SE 1-48 1-73
.N 11.0 12-0
Seriew .1V(200,000 cells):
Mean 0-96 1-7 1.05
SE 0-264 0.576 0-231
N 11.0 9.0 12-0
Autopsies revealed no unusual findings; no signs of concurrent infections
were noted.
It is difficult to evaluate the results of the microscopic examination of the
ascitic fluids from these mice since the individual animals died at different time
intervals after inoculation. Nevertheless, it was noted that ascitic fluids from
animalstreatedwithnucleotides contained less cancer cells and moreinflammatory
ceHs than those from control animals. In a number of cases nucleotide-treated
animals had no ascites at all or developed an intra-abdominal solid tumor which
may be, according to Klein (1950) and Klein and Klein (1951), a sign of low
tumor virulence. No such phenomenon was noted in control animals. These
results suggest that nucleotides may decrease the virulence of intraperitoneally
injected cancer cells, yet the nucleotides are more toxic to cancer-bearing mice
than to normal animals.
DISCUSSION.
Greenberg (1949) demonstrated that adenosine-5-phosphoric acid inhibits
anaerobic glycolysis of brain preparations, while adenosine-3-phosphoric acid
andadenosinetriphosphate have nosucheffect. Fischer, Wehmeier andJiingling
(1934) described the neuro-inductor effect of adenosine-5-phosphoric acid, while
Suomalainen and Toivonen (1939) could not obtain similar results with adenosine-
3-phosphoric acid. Green and Bullough (1950) showed thatlarge doses ofadeno-
sine triphosphate greatly decrease the mitotic activity in the skin of mice. All
these data suggested theinvestigation ofthe action ofthese nucleotides on tumor
growth.
Mitchell (1942, 1943) pointed out that after X-ray or y irradiation ofrapidly growing cells, accumulation ofnucleotides is evidenced in the cytoplasm. Loof-
bourow (1942) demonstrated a release of nucleotides from tissues exposed to
ultraviolet irradiation. It is possible that release ofnucleotides and their deriva-
tives from mahgnant tissue duringtherapeutic irradiation, necrosis or mechanical
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In our experiments all three nucleotides increased the death rate in intra-
peritoneally inoculated animals. Microscopic examination, however, revealed
some evidence for thepossibleinhibitory action ofnucleotides on tumourgrowth.
This latter effect might have been due in part to the morbid condition of the
treated animals. Green and Stoner (1950) showed that certain strains of rats
bearing transplanted dibenzanthracene sarcomata exhibit decreased adenosine
triphosphate dephosphorylase activit ofthe liver. It is notimpossible that this
factorplayed a role in the increased nucleotidesensitivity ofmicebearing Ehrhch
ascitic tumors. No increased toxicity of nucleotides was evidenced in animals
'th subcutaneous tumors. In these groups adenosine-3-phosphoric acid signifi-
cantly decreased tumorsize, andadenosine-5-phosphoric acid had aslightgrowth-
increasing effect, while adenosine triphosphate was ineffective. Similar
differences between the biological actions of these nucleotides were also noted
by other authors in different fields ofinvestigation as mentioned above.
SUMMARY.
1. Adenosine-3-phosphoric acid inhibits growth of subcutaneous Ehrlich
carcinoma. Adenosine-5-phosphoric acid rather enhances tumorgrowth, whereas
adenosine triphosphate has no effect.
2. All three of the nucleotides brought about an increase in the death rate of
animals inoculated intraperitoneaRy with Ehrhch carcinoma. The number of
cancer ceRs, however, was smaHer in the ascitic fluid of the nucleotide-treated
mice than in the control animals.
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